Prof. Zheng Shusen, MD, PhD, FACS
Hepatobiliary & Liver Transplant Surgeon
-
Position :Academician of the Chinese Academy of Engineering, Chief Physician, Foreign Member of the French National Academy of Medicine, Professor and Doctoral Supervisor of at Zhejiang University.
-
Specialty :Innovation and promotion of liver transplantation techniques.
-
Affiliated Hospital :Shulan (Hangzhou) Hospital
-
Department :Hepatobiliary and Pancreatic Surgery
Overview
The Department of Hepatobiliary and Pancreatic Surgery at Shulan (Hangzhou) Hospital is led by a distinguished expert in hepatobiliary and pancreatic surgery and organ transplantation and is equipped with world-class technical capabilities. The department performs all conventional surgeries and laparoscopic minimally invasive treatments for the liver, bile duct, pancreas, and spleen. Its extensive experience and mature techniques cover complex liver tumors, gallstone disease, intrahepatic and extrahepatic bile duct stones, bile duct tumors, pancreatic tumors, severe pancreatitis, and portal hypertension. The department offers a range of services, including specialist outpatient clinics, expert consultations, and surgeries performed by leading physicians.
With access to cutting-edge minimally invasive surgical equipment, the department has achieved proficiency in robotic pancreaticoduodenectomy, pancreatic body and tail resection, and complex liver surgeries. Its international telemedicine multidisciplinary consultation platform (iMDT) collaborates with renowned medical centers across the US, Europe, Australia, Japan, Hong Kong, and Taiwan. The department provides authoritative diagnostic and treatment services for abdominal diseases, as well as international telemedicine consultation and US referral services.
Expert Introduction
Professor Zheng Shushen, a Chinese Academy of Engineering Academician and a world-leading authority in organ transplantation and hepatobiliary surgery, has performed over 4,000 liver transplants, including living donor liver transplants, split liver transplants, combined liver-kidney transplants, and pancreas transplants. He participated as the first assistant in the first human orthotopic liver transplant at Queen Mary Hospital of Hong Kong University in October 1991. In June 2001, he performed mainland China’s first adult living donor liver transplant using the right lobe. In 1994, he conducted a combined pancreas-kidney transplant, and in 1999, a combined liver-kidney transplant. Two recipients hold Asia’s longest survival record post-combined pancreas-kidney transplant (14 years) and mainland China’s longest survival record post-combined liver-kidney transplant (9 years). Professor Zheng is the lead specialist of the National Basic Research Program (973 Program) titled “Basic Research on Immunological Mechanisms of Chronic Graft Dysfunction.” He has published over 400 papers in international journals such as Liver Transplantation and Transplantation, with 175 indexed by SCI. He has authored several monographs, including Liver Transplantation, Pancreas Transplantation, and Management in the Perioperative Period of Liver Transplantation. He is also the chief editor of the journal Hepatobiliary & Pancreatic Diseases International (SCI-indexed), the first English-language professional journal in China in the field of hepatobiliary and pancreatic diseases. In 2013, he was awarded the Li Madam Science and Technology Progress Award by the Ho Leung Ho Lee Foundation and was named one of CCTV’s 2016 Annual Innovative Figures.
Achievements and Experience
- Member of the American College of Medical and Biological Engineering
- Foreign Member of the French National Academy of Medicine
- Director of the National Health Commission’s Key Laboratory for Multi-organ Combined Transplantation Research
- Vice President of the Chinese Medical Association
- Vice President of the Chinese Medical Doctor Association
- President of the Chinese Medical Doctor Association’s Organ Transplantation Physicians Branch
- Chairman of the Scientific Committee of the China Liver Transplant Registry
- Director of the Zhejiang University Organ Transplantation Research Institute
- Fellow of the American College of Surgeons (FACS) and UCLA “Distinguished Professor”
Achievements and Experience
- Recipient of 1 National Science and Technology Progress First Prize and 2 Second Prizes
- Honored with the National Science and Technology Progress Award for Innovative Teams
- Awarded the Ho Leung Ho Lee Science and Technology Progress Prize
- Developed a novel prophylactic regimen for post-transplant hepatitis B recurrence using low-dose HBIG in combination with nucleoside analogs
- Established a technical system for adult right lobe living-donor liver transplantation
- Led 2 “973 Program” projects, 2 major special projects, and 3 innovative research groups
- Devised the “Hangzhou Criteria” for liver cancer liver transplantation recipient selection, which has been adopted as a national standard
- Published over 400 SCI-indexed papers in top-tier journals as a first author and corresponding author
- Authored 10 monographs and served as editor-in-chief for 2 journals, one of which is SCI-indexed
- Recognized as the 2016 Annual Innovative Figure by China Central Television